Key Metrics
Income Statement
Balance Sheet
Cash Flow
Shareholder Return
Unit: HKD
FY 2013
FY 2014
FY 2015
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Gross margin 45.58% -- 47.56% 46.39% -- -- -- -- -- -- -- -- -- -- 57.54% -- 58.81% 59.22% 45.67% 45.85% -- --
Net margin 10.97% -- 11.16% 8.32% -- -- -- -- -- -- -- -- -- -- 22.06% -- 33.46% 18.05% 4.09% 4.13% -- --
ROE 39.82% -- 43.88% 29.33% -- -- -- -- -- -- -- -- -- -- 35.22% -- 50.58% 22.38% 3.16% 3.37% -- --
ROA 25.75% -- 26.44% 15.40% -- -- -- -- -- -- -- -- -- -- 23.59% -- 32.39% 14.31% 2.29% 2.48% -- --
Revenue growth -- -- 9.38% -- 17.60% -- -- -- -- -- -- -- -- -- -- -- -- 76.10% -- -3.73% -41.62% 8.99% -- --
Attributable profit growth -- -- 13.65% -- -12.96% -- -- -- -- -- -- -- -- -- -- -- -- 167.03% -- -48.05% -86.76% 8.79% -- --
Debt-to-assets 34.09% -- 36.39% 50.41% -- -- -- -- -- -- -- -- -- -- 33.03% -- 35.96% 36.03% 27.42% 27.07% -- --
Current ratio 2.50 -- 2.35 1.44 -- -- -- -- -- -- -- -- -- -- 2.24 -- 2.43 2.28 2.84 2.88 -- --
Operating cash flow / net profit 1.06 -- 1.01 1.55 -- -- -- -- -- -- -- -- -- -- 0.59 -- 0.79 3.67 0.55 3.70 -- --
Operating cash flow / revenue 11.67% -- 11.32% 12.86% -- -- -- -- -- -- -- -- -- -- 13.06% -- 26.37% 66.31% 2.24% 15.30% -- --
Unit: HKD
FY 2013
FY 2014
FY 2015
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Revenue 333.93M -- 365.25M 429.54M -- -- -- -- -- -- -- -- -- -- 544.77M -- 959.35M 923.59M 539.23M 587.69M -- --
Other income and gains 2.48M -- 580.00K 1.81M -- -- -- -- -- -- -- -- -- -- 22.40M -- 27.64M 3.12M 27.58M 11.80M -- --
Cost of sales 181.74M -- 191.53M 230.29M -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross profit 152.19M -- 173.72M 199.25M -- -- -- -- -- -- -- -- -- -- 313.44M -- 564.16M 546.95M 246.29M 269.44M -- --
Administrative expenses 111.03M -- 124.94M 155.88M -- -- -- -- -- -- -- -- -- -- 191.90M -- 206.81M 320.82M 240.96M 247.75M -- --
Net finance costs -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 2.44M -- 2.51M 7.65M 7.50M 5.97M -- --
Income tax 7.00M -- 8.60M 9.46M -- -- -- -- -- -- -- -- -- -- 20.28M -- 59.82M 53.45M 2.17M 3.02M -- --
Operating profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 142.09M -- 384.98M 229.26M 32.91M 33.50M -- --
Share of associates and JVs 0 -- 0 -- 0 -- -- -- -- -- -- -- -- -- -- -- 823.76K -- -1.69M -1.42M -1.16M -217.04K -- --
Profit before tax 43.63M -- 49.36M 45.18M -- -- -- -- -- -- -- -- -- -- 140.47M -- 380.78M 220.18M 24.24M 27.31M -- --
Net profit 36.63M -- 40.76M 35.72M -- -- -- -- -- -- -- -- -- -- 120.20M -- 320.96M 166.73M 22.08M 24.29M -- --
Net profit attributable to owners 34.09M -- 38.75M 33.73M -- -- -- -- -- -- -- -- -- -- 120.20M -- 320.96M 166.73M 22.08M 24.02M -- --
Cash and cash equivalents
Unit: HKD
FY 2013
FY 2014
FY 2015
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Cash and cash equivalents 88.33M -- 91.42M 109.25M -- -- -- -- -- -- -- -- -- -- 120.87M -- 231.19M 591.23M 446.83M 401.17M -- --
Trade and bills receivables 21.42M -- 24.84M 31.89M -- -- -- -- -- -- -- -- -- -- 194.28M -- 361.18M 93.70M 39.88M 56.95M -- --
Inventories 3.67M -- 4.80M 7.29M -- -- -- -- -- -- -- -- -- -- 11.62M -- 15.67M 26.12M 29.46M 22.87M -- --
Total current assets 121.15M -- 131.86M 164.31M -- -- -- -- -- -- -- -- -- -- 346.04M -- 625.94M 734.81M 560.03M 535.91M -- --
Total assets 142.27M -- 154.13M 231.92M -- -- -- -- -- -- -- -- -- -- 509.56M -- 990.84M 1.16B 964.13M 977.58M -- --
Total current liabilities 48.36M -- 56.00M 114.14M -- -- -- -- -- -- -- -- -- -- 154.20M -- 257.49M 321.93M 196.97M 185.78M -- --
Total liabilities 48.50M -- 56.08M 116.92M -- -- -- -- -- -- -- -- -- -- 168.29M -- 356.33M 419.75M 264.41M 264.67M -- --
Equity attributable to owners 85.61M -- 88.30M 115.00M -- -- -- -- -- -- -- -- -- -- 341.26M -- 634.50M 745.16M 699.72M 712.92M -- --
Total equity 93.77M -- 98.05M 115.00M -- -- -- -- -- -- -- -- -- -- 341.26M -- 634.50M 745.16M 699.72M 712.92M -- --
Net cash from operating activities
Unit: HKD
FY 2013
FY 2014
FY 2015
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Net cash from operating activities 38.97M -- 41.35M 55.23M -- -- -- -- -- -- -- -- -- -- 71.14M -- 252.98M 612.44M 12.05M 89.91M -- --
Net cash from investing activities -5.80M -- -6.96M -31.90M -- -- -- -- -- -- -- -- -- -- -3.97M -- -173.79M -309.18M -43.48M 3.39M -- --
Net cash from financing activities -18.33M -- -31.30M -5.50M -- -- -- -- -- -- -- -- -- -- -49.34M -- -57.68M -164.38M -113.65M -86.57M -- --
Net change in cash 14.84M -- 3.09M 17.83M -- -- -- -- -- -- -- -- -- -- 17.82M -- 21.51M 138.88M -145.07M 6.73M -- --
Dividends
Dividend per share (last 12 months) 0.03 HKD
Dividend yield +3.75%
Payments (last 12 months) 1
Sum of per-share cash dividends already ex-dividend, as of 2025-12-15; amounts in different currencies are not converted.
Dividend Details
Dividend Details
Ex-date
Payment Date
Record Date
HKD 3.1Final
2027-01-05
2026-12-16
HKD 0.03Final
每股派港币0.03元
2025-12-15
2026-01-05
2025/12/17-2025/12/18
HKD 0.028Final
每股派港币0.028元
2024-12-04
2024-12-30
2024/12/06-2024/12/10
HKD 0.16Final
每股派港币0.16元
2023-12-11
2023-12-29
2023/12/13-2023/12/15
HKD 0.3Final
每股派港币0.3元
2022-12-06
2022-12-23
2022/12/08-2022/12/09
HKD 0.12Final
每股派港币0.12元
2021-12-07
2021-12-28
2021/12/09-2021/12/13
HKD 0.03Final
每股派港币0.03元
2019-12-03
2019-12-23
2019/12/05-2019/12/09
HKD 0.03Final
每股派港币0.03元
2018-12-04
2018-12-21
2018/12/06-2018/12/07
HKD 0.02Final
每股派港币0.02元
2017-12-04
2017-12-21
2017/12/06-2017/12/07
HKD 0.03Final
每股派港币0.03元
2016-12-01
2016-12-20
2016/12/05-2016/12/06
Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.
About this page
This page shows HUMAN HEALTH (01419) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.
Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect
